Medtronic chest compression system cleared
This article was originally published in The Gray Sheet
Medtronic subsidiary Physio-Control will begin shipping its next-generation Lucas 2 chest compression system in the U.S. this fall, following 510(k) clearance June 23, the firm says. Lucas 2 is an automated, battery-powered device designed to give uninterrupted compressions to patients in cardiac arrest, to facilitate the return of spontaneous circulation. Unlike Lucas 1, Lucas 2 is electric rather than pneumatic. The product is developed and manufactured by Lund, Sweden-based Jolife and distributed in the U.S. by Medtronic/Physio-Control
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.